Skip to main content
Log in

Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant

  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  • Allgrove J (1997) Bisphosphonates. Arch Dis Child 76: 73-75.

    Google Scholar 

  • Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339: 947-952.

    Google Scholar 

  • Plotkin H, Rauch F, Bishop NJ, et al (2000) Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 85: 1846-1850.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W.-L. Hwu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chien, YH., Chu, SY., Hsu, CC. et al. Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant. J Inherit Metab Dis 25, 593–595 (2002). https://doi.org/10.1023/A:1022099425316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022099425316

Navigation